細胞療法市場：按治療方法、適應症、最終用戶和地區分類

Cell Therapy Market, By Therapy Type, By Indication, By End User, By Geography

出版日期: 2026年03月16日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，細胞治療市場規模將達到31.096億美元，到2033年將達到59.831億美元。預計從2026年到2033年，其複合年成長率將達到9.8%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	31.096億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	9.80%	2033年市場規模預測：	59.831億美元

未來十年，全球細胞治療市場預計將迎來顯著成長，其主要驅動力是慢性病盛行率的上升和全球人口老化。細胞治療是一個新興且前景廣闊的領域，它利用活細胞修復、替換或再生受損組織和細胞。細胞培養技術、相關技術的進步以及監管核准的不斷完善，推動了用於治療血液疾病、癌症、自體免疫疾病等多種疾病的新療法的研發。隨著研發投入的大幅成長和監管核准的不斷完善，細胞治療產業有望在不久的將來徹底改變醫療保健產業。

市場動態

全球細胞治療市場成長的促進因素包括癌症和其他慢性疾病發生率的上升、細胞研究經費的增加以及新型治療方法開發技術的進步。此外，全球老年人口的成長及其易感人群預計也將推動市場需求。然而，細胞療法開發的高成本以及對新型治療方法的嚴格監管限制了市場成長。中國、印度和巴西等新興經濟體由於醫療保健投資的不斷增加，為市場相關人員提供了極具吸引力的機會。預計在預測期內，幹細胞研究和細胞療法新應用的持續發展將開闢新的發展道路。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球細胞治療市場的主要參與者進行了分析：公司概況、產品系列、主要亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
全球細胞治療市場涵蓋了該行業的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球細胞治療市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

公司簡介
- Bristol Myers Squibb Company
- Amgen Inc.
- Novartis AG
- Gilead Sciences, Inc.
- Johnson & Johnson Services, Inc.
- Allogene Therapeutics
- Athersys, Inc.
- Orchard Therapeutics
- JW Therapeutics Co., Ltd.
- Dendreon Pharmaceuticals LLC.
- Autolus Therapeutics
- APAC Biotech
- CORESTEM, Inc.
- BioCardia, Inc.
- JCR Pharmaceuticals Co., Ltd.
- Oxford Biomedica
- CASI Pharmaceuticals Inc.

第9章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第10章參考文獻與調查方法

參考
調查方法

簡介目錄

Product Code: CMI5413

Cell Therapy Market is estimated to be valued at USD 3,109.6 Mn in 2026 and is expected to reach USD 5,983.1 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.8% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3,109.6 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.80%	2033 Value Projection:	USD 5,983.1 Mn

Global cell therapy market is expected to witness growth substantially over the next decade due to rising prevalence of chronic diseases coupled with increasing geriatric population globally. Cell therapy is an emerging and promising field that works with living cells to repair, replace or regenerate damaged tissues and cells. Advancements in cell culture techniques, associated technologies and regulatory approvals have supported the development of new therapies to treat blood disorders, cancers, autoimmune diseases and others. With significant investments in research and development and growing regulatory approvals, the cell therapy industry is poised to transform healthcare in the near future.

Market Dynamics

Global cell therapy market growth is driven by factors such as rising prevalence of cancer and other chronic diseases, increase in funds for cell-based research, and advancement of technologies to develop novel therapies. Moreover, growing geriatric population worldwide prone to diseases is expected to boost demand. However, high costs associated with cell therapy development and stringent regulations for new therapies limits the market growth. Emerging economies offer lucrative opportunities for market players due to growing healthcare investments in countries like China, India and Brazil. Continuous research on stem cells and new applications of cell therapy are anticipated to create new avenues over the forecast period.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
It profiles key players in the global cell therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
Key companies covered as a part of this study Bristol Myers Squibb Company, Amgen Inc., Novartis AG, Gilead Sciences, Inc., Johnson & Johnson Services, Inc., Allogene Therapeutics, Athersys, Inc., Orchard Therapeutics, JW Therapeutics Co., Ltd., Dendreon Pharmaceuticals LLC., Autolus Therapeutics, APAC Biotech, CORESTEM, Inc., BioCardia, Inc., JCR Pharmaceuticals Co., Ltd., Oxford Biomedica, and CASI Pharmaceuticals Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
Global cell therapy market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cell therapy market.

Market Segmentation

Therapy Type Insights (Revenue, USD Mn, 2021 - 2033)
Stem Cells
T-cells
Dendritic Cells
NK-cells
Indication Insights (Revenue, USD Mn, 2021 - 2033)
Oncology
Cardiology
Neurology
Others
End User Insights (Revenue, USD Mn, 2021 - 2033)
Hospitals
Clinics
Research Institutes
Regional Insights (Revenue, USD Mn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Bristol Myers Squibb Company
Amgen Inc.
Novartis AG
Gilead Sciences, Inc.
Johnson & Johnson Services, Inc.
Allogene Therapeutics
Athersys, Inc.
Orchard Therapeutics
JW Therapeutics Co., Ltd.
Dendreon Pharmaceuticals LLC.
Autolus Therapeutics
APAC Biotech
CORESTEM, Inc.
BioCardia, Inc.
JCR Pharmaceuticals Co., Ltd.
Oxford Biomedica
CASI Pharmaceuticals Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Therapy Type
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Opportunities
Impact Analysis
Market Trends
Recent Developments
Regulatory Scenario
Technological Advancements
Manufacturer Revenue
Acquisitions and Partnerships Scenario
Product Launches/Approvals
Fundings and Investments
PEST Analysis
Porter's Analysis

4. Global Cell Therapy Market, By Therapy Type, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Stem Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
T-cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Dendritic Cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
NK-cells
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

5. Global Cell Therapy Market, By Indication, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Oncology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Cardiology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Neurology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

6. Global Cell Therapy Market, By End User, 2021 - 2033, (USD Mn)

Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
Research Institutes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)

7. Global Cell Therapy Market, By Region, 2021 - 2033, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Company Profiles
- Bristol Myers Squibb Company
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Amgen Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Gilead Sciences, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Johnson & Johnson Services, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Allogene Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Athersys, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Orchard Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- JW Therapeutics Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Dendreon Pharmaceuticals LLC.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Autolus Therapeutics
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- APAC Biotech
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- CORESTEM, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- BioCardia, Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- JCR Pharmaceuticals Co., Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- Oxford Biomedica
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
- CASI Pharmaceuticals Inc.
  - Company Highlights
  - Product Portfolio
  - Key Highlights
  - Financial Performance
  - Market Strategies
  - Financial Performance